1. Antiepileptic drugs: patients link cognitive impairment with medication

   Media release 21 January 2013 Pages: 2 - 2

2. Budesonide: US FDA upgrades pregnancy rating to Category B

   Media release 21 January 2013 Pages: 2 - 2

3. Health Canada announces recall of potassium replacement products

   News item 21 January 2013 Pages: 2 - 2

4. UK MHRA reiterates concerns regarding Chinese medicines

   News item 21 January 2013 Pages: 2 - 2

5. US Geodon label change reflects hyperglycaemia risk

   News item 21 January 2013 Pages: 2 - 2

6. Dietary supplement use and the US regulatory framework

   Comment 21 January 2013 Pages: 3 - 3

7. Hepatitis B vaccine: no link with neonatal death

   Incidence study 21 January 2013 Pages: 3 - 3

8. Long-term tacrolimus tolerable in rheumatoid arthritis

   News item 21 January 2013 Pages: 3 - 3

9. Antenatal dexamethasone: multiple courses should not be routine

   Clinical study 21 January 2013 Pages: 4 - 4

10. COX-2s preferred over nonselective NSAIDs in coumarin recipients

    Clinical study 21 January 2013 Pages: 4 - 4

11. Preventing GI complications only cost effective in patients at risk

    Clinical study 21 January 2013 Pages: 4 - 4

12. Nesiritide well tolerated in congestive heart failure

    Media release 21 January 2013 Pages: 5 - 5

13. Pergolide associated with valvular heart disorders

    Clinical study 21 January 2013 Pages: 5 - 5

14. Rifampicin/pyrazinamide: risk of hepatotoxicity variable?

    News item 21 January 2013 Pages: 5 - 5

15. Androstenediol/testosterone

    Case reports 21 January 2013 Pages: 6 - 6

16. Antiretrovirals

    Case report 21 January 2013 Pages: 6 - 6

17. Atazanavir

    Case report 21 January 2013 Pages: 7 - 7

18. Bosentan

    Case report 21 January 2013 Pages: 7 - 7

19. Candesartan cilexetil

    Case report 21 January 2013 Pages: 7 - 7

20. Cyclophosphamide/doxorubicin

    Case report 21 January 2013 Pages: 7 - 8

21. Dexamfetamine

    Case report 21 January 2013 Pages: 8 - 8

22. Efavirenz interaction

    Case report 21 January 2013 Pages: 8 - 8

23. Efavirenz/lamivudine/zidovudine

    Case report 21 January 2013 Pages: 8 - 9

24. Enfuvirtide

    Case report 21 January 2013 Pages: 9 - 9

25. Famotidine

    Case reports 21 January 2013 Pages: 9 - 9

26. Fluoxetine interaction

    Case report 21 January 2013 Pages: 9 - 10

27. Ganciclovir

    Case report 21 January 2013 Pages: 10 - 10

28. Haloperidol withdrawal

    Case report 21 January 2013 Pages: 10 - 10

29. Immunosuppressants

    Case report 21 January 2013 Pages: 10 - 10

30. Infliximab

    Case report 21 January 2013 Pages: 10 - 11

31. Leflunomide

    Case report 21 January 2013 Pages: 11 - 11

32. Linezolid

    Case report 21 January 2013 Pages: 11 - 11

33. Lorazepam

    Case report 21 January 2013 Pages: 11 - 11

34. Methysergide

    Case report 21 January 2013 Pages: 11 - 12

35. Nifedipine

    Case reports 21 January 2013 Pages: 12 - 12

36. Ofloxacin

    Case report 21 January 2013 Pages: 12 - 12

37. Peplomycin

    Case report 21 January 2013 Pages: 12 - 13

38. Rosiglitazone

    Case report 21 January 2013 Pages: 13 - 13

39. Sodium polystyrene sulfonate

    Case report 21 January 2013 Pages: 13 - 13

40. Sulbactam/ampicillin

    Case report 21 January 2013 Pages: 13 - 13

41. Sulfasalazine

    Case report 21 January 2013 Pages: 14 - 14

42. Valproic acid

    Case report 21 January 2013 Pages: 14 - 14

43. Vancomycin interaction

    Case report 21 January 2013 Pages: 14 - 15